Post-translational modifications (PTMs) of both tau and α-synuclein play crucial roles in synucleinopathies and tauopathies, potentially influencing their aggregation and contributing to the neurodegenerative pathogenesis [15, 16]. This evidence concerns the gene MAPT and tauopathy.